MLchartDataset catalogue

glimepiride

Term · Oncology and biomedicine · MLC-T-ONC-013957

A long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.

Table 1. Record
IdentifierMLC-T-ONC-013957
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013957",
  "term": "glimepiride",
  "field": "Oncology and biomedicine",
  "definition": "A long-acting, third-generation sulfonylurea with hypoglycemic activity. Compared to other generations of sulfonylurea compounds, glimepiride is very potent and has a longer duration of action. This agent is metabolized by CYP2C9 and shows peroxisome proliferator-activated receptor gamma (PPARgamma) agonistic activity.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/glimepiride/"
}

Record 8,015 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.